Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β

Medical Oncology

Volumn 29, Issue 4, 2012, Pages 2640-2648

  Tang, Hexiao ^a   Liao, Yongde ^a   Chen, Guang ^a   Xu, Liqiang ^a,b   Zhang, Chao ^a,c   Ju, Sheng ^a,d   Zhou, Sheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

^c CENTRAL HOSPITAL OF WUHAN   (China)

^d ZHEJIANG HOSPITAL   (China)

Author keywords

A549 cells; Estrogen receptor ; Insulin like growth factor 1 receptor; Non small cell lung cancer; Tissue microarray immunohistochemistry

Indexed keywords

AROMATASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UPREGULATION;

AGED; AROMATASE; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS;

EID: 84867976200     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0198-8     Document Type: Article

References (42)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. doi: 10.3322/caac.20107.
2. Yang GH, Wang JF, Wan X, Wang LJ, Chen AP. Quantitative analysis of factors affected mortality trend in Chinese, 2002. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26(12):934-8.
3. Stabile LP, Siegfried JM. Estrogen receptor pathways in lung cancer. Curr Oncol Rep. 2004;6(4):259-67.
4. Zhang G, Liu X, Farkas AM, Parwani AV, Lathrop KL, Lenzner D, et al. Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells. Mol Endocrinol. 2009;23(2):146-56. doi: 10.1210/me.2008-0431.
5. Fagan DH, Yee D. Crosstalk between IGF1R and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia. 2008;13(4):423-9. doi: 10.1007/s10911-008-9098-0.
6. Boccardo F, Rubagotti A, Battaglia M, Zattoni F, Bertaccini A, Romagnoli A, et al. Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients. Int J Biol Markers. 2006;21(2):123-6.
7. Kanagaraj P, Vijayababu MR, Ilangovan R, Senthilkumar K, Venkataraman P, Aruldhas MM, et al. Effect of 17beta-estradiol on apoptosis, IGF system components and gelatinases A and B in prostate cancer cells (PC-3). Clin Chim Acta. 2007;377(1-2):70-8. doi: 10.1016/j.cca.2006.07.030.
8. Maki RG. Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol. 2010;28(33):4985-95. doi: 10.1200/JCO.2009.27.5040.
9. Samani AA, Yakar S, LeRoith D, Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev. 2007;28(1):20-47. doi: 10.1210/er.2006-0001.
10. Liao Y, Abel U, Grobholz R, Hermani A, Trojan L, Angel P, et al. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade. Hum Pathol. 2005;36(11):1186-96. doi: 10.1016/j.humpath.2005.07.023.
11. Liao YD, Zhao JP, Zhou S, Fu SL, Wan YQ, Doris M. The correlation between IGF1, IGF2 expression and lymph node metastasis in non-small cell lung cancer [in Chinese]. Cancer Res Prev Treat. 2006;33(12):868-71.
12. Liao YD, Zhou S, Zhao JP, Yuan YH, Huang Q, Doris M. Expression and significance of IGF1, IGF1R and AKT, the components of IGF signaling pathway, in primary adenocarcinoma of the lung. [in Chinese]. J Pract Oncol. 2006;21(1):15-9.
13. Dziadziuszko R, Camidge DR, Hirsch FR. The insulin-like growth factor pathway in lung cancer. J Thorac Oncol. 2008;3(8):815-8. doi: 10.1097/JTO.0b013e31818180f5.
14. Ryan PD, Goss PE. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist. 2008;13(1):16-24. doi: 10.1634/theoncologist.2007-0199.
15. Bogazzi F, Raggi F, Ultimieri F, Russo D, D'Alessio A, Manariti A, et al. Regulation of cardiac fatty acids metabolism in transgenic mice overexpressing bovine GH. J Endocrinol. 2009;201(3):419-27. doi: 10.1677/JOE-08-0194.
16. Schon J, Neumann S, Wildt DE, Pukazhenthi BS, Jewgenow K. Localization of oestrogen receptors in the epididymis during sexual maturation of the domestic cat. Reprod Domest Anim. 2009;44(Suppl 2):294-301. doi: 10.1111/j.1439-0531. 2009.01391.x.
17. Klein C, Scoggin KE, Ealy AD, Troedsson MH. Transcriptional profiling of equine endometrium during the time of maternal recognition of pregnancy. Biol Reprod. 2010;83(1):102-13. doi: 10.1095/biolreprod.109.081612.
18. Galic S, Klingler-Hoffmann M, Fodero-Tavoletti MT, Puryer MA, Meng TC, Tonks NK, et al. Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol Cell Biol. 2003;23(6):2096-108.
19. Augustine-Rauch KA, Zhang Q, Kleinman M, Lawton R, Welsh MJ. A study of vehicles for dosing rodent whole embryo culture with non aqueous soluble compounds. Reprod Toxicol. 2004;18(3):391-8. doi: 10.1016/j.reprotox.2004.01. 006.
20. Kang KF, Wang XW, Chen XW, Shi XC. Expression and clinical significance of Beclin1 and NF-κB p65 protein in primary human hepatocellular carcinoma. [in Chinese]. World Chin J Digestol. 2008;16(20):2244-7.
21. Yang XR, Pfeiffer RM, Garcia-Closas M, Rimm DL, Lissowska J, Brinton LA, et al. Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study. Cancer Res. 2007;67(21):10608-17. doi: 10.1158/0008-5472.CAN-07-2142.
22. Marquez DC, Lee J, Lin T, Pietras RJ. Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor. Endocrine. 2001;16(2):73-81. doi: 10.1385/ENDO:16:2:073.
23. Marquez DC, Pietras RJ. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene. 2001;20(39):5420-30. doi: 10.1038/sj.onc.1204729.
24. Sunwoo H, Gujral N, Suresh M. Competitive and double antibody sandwich ELISA for the quantification of lactoferrins by using monoclonal and chicken egg yolk IgY antibodies. J Immunoassay Immunochem. 2011;32(2):79-92. doi: 10.1080/15321819.2010.543218.
25. Tkaczuk KH, Tait NS, Ioffe O, Tan M, Goloubeva OG, Lesko SA, et al. Computer assisted quantitative immunofluorescence of tumor tissue marker expression and clinical outcome to chemotherapy in advanced breast cancer patients. Discov Med. 2011;12(62):33-40.
26. Chang MM, Lovett J. A laboratory exercise illustrating the sensitivity and specificity of Western blot analysis. Biochem Mol Biol Educ. 2011;39(4):291-7. doi: 10.1002/bmb.20501.
27. McCance KL, Jones RE. Estrogen and insulin crosstalk: breast cancer risk implications. Nurse Pract. 2003;28(5):12-23; quiz 4-5.
28. Weinberg OK, Marquez-Garban DC, Fishbein MC, Goodglick L, Garban HJ, Dubinett SM, et al. Aromatase inhibitors in human lung cancer therapy. Cancer Res. 2005;65(24):11287-91. doi: 10.1158/0008-5472.CAN-05-2737.
29. Niikawa H, Suzuki T, Miki Y, Suzuki S, Nagasaki S, Akahira J, et al. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Clin Cancer Res. 2008;14(14):4417-26. doi: 10.1158/1078-0432.CCR-07- 1950.
30. Hershberger PA, Stabile LP, Kanterewicz B, Rothstein ME, Gubish CT, Land S, et al. Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. J Steroid Biochem Mol Biol. 2009;116(1-2):102-9. doi: 10.1016/j.jsbmb.2009.05.004.
31. Zhao G, Zhao S, Wang T, Zhang S, Lu K, Yu L, et al. Estrogen receptor beta signaling regulates the progression of Chinese non-small cell lung cancer. J Steroid Biochem Mol Biol. 2011;124(1-2):47-57. doi: 10.1016/j.jsbmb.2011.01. 006.
32. Miki Y, Suzuki T, Abe K, Suzuki S, Niikawa H, Iida S, et al. Intratumoral localization of aromatase and interaction between stromal and parenchymal cells in the non-small cell lung carcinoma microenvironment. Cancer Res. 2010;70(16):6659-69. doi: 10.1158/0008-5472.CAN-09-4653.
33. Lindblad M, Garcia RL, Chandanos E, Lagergren J. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer. 2006;94(1):136-41. doi: 10.1038/sj.bjc.6602906.
34. Mollerup S, Jorgensen K, Berge G, Haugen A. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer. 2002;37(2):153-9.
35. Hershberger PA, Vasquez AC, Kanterewicz B, Land S, Siegfried JM, Nichols M. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res. 2005;65(4):1598-605. doi: 10.1158/0008-5472.can-04-2694.
36. Schwartz AG, Prysak GM, Murphy V, Lonardo F, Pass H, Schwartz J, et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res. 2005;11(20):7280-7. doi: 10.1158/1078-0432.CCR-05-0498.
37. Ali G, Donati V, Loggini B, Servadio A, Dell'Omodarme M, Prati MC, et al. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma. Hum Pathol. 2008;39(10):1465-73. doi: 10.1016/j.humpath. 2008.02.011.
38. Hammoud Z, Tan B, Badve S, Bigsby RM. Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma. Endocr Relat Cancer. 2008;15(2):475-83. doi: 10.1677/ERC-08-0002.
39. Skov BG, Fischer BM, Pappot H. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer. 2008;59(1):88-94. doi: 10.1016/j.lungcan.2007.07.025.
40. Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, et al. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res. 2005;11(14):5084-9. doi: 10.1158/1078-0432.ccr-05-0200.
41. Wu CT, Chang YL, Shih JY, Lee YC. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg. 2005;130(4):979-86. doi: 10.1016/j.jtcvs.2005.06.012.
42. Carmona-Bayonas A. Potential benefit of maintenance trastuzumab and anastrozole therapy in male advanced breast cancer. Breast. 2007;16(3):323-5. doi: 10.1016/j.breast.2006.12.010.